Journal

New scientific paper exposes serious flaws in fluoride-IQ studies

Retrieved on: 
Monday, March 25, 2024
Deficit spending, Pregnancy, Health, Conditional sentence, Database, Public health, BMC Public Health, Intelligence, Risk, Bias, Family medicine, JAMA Pediatrics, Journal, Fetus, Research, Tooth decay, Policy, Water, American Academy, University, American Dental Association, Systematic review, Drinking, Intelligence quotient, Pediatrics (journal), Pediatrics, Meta-analysis, Bottled water

WASHINGTON, March 25, 2024 /PRNewswire/ -- Hundreds of millions of people around the world receive significant dental health benefits because their tap water is adjusted to the recommended amount of fluoride. Yet opponents of water fluoridation often cite a 2019 Canadian study (Green et al.) to claim that fluoride affects children's IQ scores. This claim has been refuted by a new peer-reviewed analysis. This published analysis shows that the Canadian researchers relied on data that cannot report fluoride measurement and does not accurately measure IQ.

Key Points: 
  • The authors of this analysis wrote that studies relying on these data to make claims about fluoride and IQ "should be considered unacceptable for legal and policy purposes."
  • When the researchers compared the average IQ score between fluoridated and non-fluoridated cities in Canada, the scores were virtually identical.
  • In fact, a 2023 systematic review examined 30 fluoride-IQ studies and found that 29 studies were at moderate to high risk of bias (lower quality).
  • For more information on the scientific evidence related to fluoride and fluoridation, please visit the American Fluoridation Society at AmericanFluoridationSociety.org.

Legacy's Research Team Announces Publication of 9th paper

Retrieved on: 
Monday, March 25, 2024
Attention, Advisory board, Risk, Public, Journal, Research, Fertility, Website, Socioeconomics, The Journal of Urology, Male, Harvard University, Health, ASRM, Stanford University, Reproductive medicine, Birth control

NEW YORK, March 25, 2024 /PRNewswire/ -- As part of Legacy's ongoing initiative to advance the field of male fertility, the team is proud to announce its 9th publication, to be published in the upcoming volume of the Journal of Urology. The paper covers the correlation between socioeconomic status and male fertility, revealing concerning trends that demand attention and additional research.

Key Points: 
  • The paper covers the correlation between socioeconomic status and male fertility, revealing concerning trends that demand attention and additional research.
  • These initiatives include supporting external research with funding, most recently to Dr. Russ Hauser at Harvard University.
  • It includes grant giving, most recently by funding the ASRM Legacy Grant, which in 2023 was awarded to Dr. Audrey Gaskins.
  • "On top of that, their continued research initiatives have been critical in advancing the field and have helped us better understand the evolving nuances of male fertility."

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

Retrieved on: 
Monday, March 25, 2024
CE marking, Temperature, Electrophysiology, Atrial fibrillation, Patient, Journal, Ventricular tachycardia, Science, McGill University Health Centre, MD, CCB, Tachycardia, Catheter ablation, Division, Arrhythmia, Catheter, Adagio, Medical device

The system consists of the upgraded cryoablation console, also capable of supporting atrial ablation procedures using commercially available iCLAS™ catheters, and the vCLAS™ ventricular cryoablation catheter ("vCLAS").

Key Points: 
  • The system consists of the upgraded cryoablation console, also capable of supporting atrial ablation procedures using commercially available iCLAS™ catheters, and the vCLAS™ ventricular cryoablation catheter ("vCLAS").
  • The system will be featured at the upcoming conference of the European Heart Rhythm Association ("EHRA") in Berlin on April 7-9, 2024 and will become immediately available for clinical use in select European centers.
  • Unlike conventional radiofrequency ("RF") catheters commonly used for both ventricular and atrial procedures, the 9Fr, bi-directional deflectable vCLAS catheter was designed specifically to address the challenges of VT ablations.
  • CE Mark approval for the vCLAS catheter has been granted based on the results of the Cryocure-VT trial, which enrolled patients with monomorphic VT of both ischemic and non-ischemic origin at nine European and Canadian centers.

XPlan.ai Confirms Premier Precision in Peer-Reviewed Clinical Study of its 2D-to-3D Knee Reconstruction Solution

Retrieved on: 
Thursday, March 21, 2024
Diagnosis, Elective surgery, Radiation, X-ray, Infection, Medicine, Patient, Anatomy, Journal, Artificial intelligence, 3D, Assuta Medical Center, Surgeon, Robotics, Journal of Clinical Medicine, Medical director, FDA, TEL, Medical imaging

TEL AVIV, Israel, March 21, 2024 /PRNewswire/ -- XPlan.ai, a spinoff of RSIP Vision that uses AI to democratize precision orthopedics, reaches a new milestone for its X-ray based 3D bone modeling system with the publication of a peer-reviewed clinical study confirming unprecedented, sub-mm accuracy in a variety of clinically relevant measurements. The study, led by a consortium of orthopedic surgeons and published in the Journal of Clinical Medicine, found that XPlan.ai offers a promising alternative to conventional CT scans, opening up the market for image-based computer-assisted surgery such as robotics, AR, and navigation while increasing efficiency, saving costs and avoiding unnecessary radiation exposure.

Key Points: 
  • XPlan.ai uses advanced artificial intelligence (AI) to produce accurate 3-dimensional bone models from two standard X-ray images.
  • The clinical benefit is lower levels of radiation exposure from X-ray imaging compared to a complete knee CT scan.
  • I am encouraged to see that the accuracy of XPlan's solution has passed the most stringent tests conducted in our study."
  • Going forward, XPlan.ai plans to apply for FDA clearance of its knee reconstruction solution.

Doctor's BiomeⓇ: Women's Health - Dietary Supplement Inhibited Pathogenic E. coli Bacteria and C. albicans Yeast

Retrieved on: 
Thursday, March 21, 2024
Food science, Urinary tract infection, Growth, Nutrition, Vaginal discharge, Health, Pelvic pain, Common, Journal, Candidiasis, UTI, Chills, Escherichia coli, Woman, Women's health, Infection, Fever, Urinary incontinence, Pain, Dietary supplement

Common UTI symptoms include urge and urinary incontinence, burning sensation while urinating, cloudy urine and pelvic pain.

Key Points: 
  • Common UTI symptoms include urge and urinary incontinence, burning sensation while urinating, cloudy urine and pelvic pain.
  • "Doctor's BiomeⓇ: Women's Health, is the first successful line extension of Doctor's BiomeⓇ.
  • Dr. Howard F. Robins, Chief Medical Officer of Doctor's BiomeⓇ explained "Our focus was to develop a proprietary dietary supplement for women that can inhibit both E. coli and C.
  • To develop Women's Health dietary supplement, we used Doctor's BiomeⓇ proprietary blend of five strains of Bifidobacteria and ten strains of Lactobacilli, as well as organic cranberry powder.

New Knee Research Finds Exactech Technologies Improve Patient Outcomes

Retrieved on: 
Wednesday, March 20, 2024
TKA, Patient, Journal, Research, Acquisition, GPS, Motion, MD, Function, Surgeon, Pain, Stanford University, Instability

"Optimizing soft tissue balance is critical to the success of total knee arthroplasty," said James Huddleston, MD, of Stanford University.

Key Points: 
  • "Optimizing soft tissue balance is critical to the success of total knee arthroplasty," said James Huddleston, MD, of Stanford University.
  • "Exactech's ligament-driven technology provides full-range intraoperative balance data, allowing surgeons to create patient-centric plans with consideration for the ever-important mid-flexion stability.
  • The results of this study are powerful in demonstrating the beauty of personalized knee arthroplasty and the importance of addressing instability and improved satisfaction."
  • The results demonstrated that Exactech's ligament-driven knee technology did not significantly increase operative time, and the patients, on average, experienced an eight-hour shorter hospital stay and yielded clinically significant improvements on Knee Society Knee and Function scores.

New Alzheimer's Association Report Reveals Top Stressors for Caregivers and Lack of Care Navigation Support and Resources

Retrieved on: 
Wednesday, March 20, 2024
Diagnosis, Organization, Prevalence, Respite care, Caregiver, Social support, Patient, Alzheimer's Association, Journal, Mortality, Quality of life, Statistics, MCI, Medicare, CMS, Report, Residential care

CHICAGO, March 20, 2024 /PRNewswire/ -- The Alzheimer's Association 2024 Alzheimer's Disease Facts and Figures report reveals that both dementia caregivers and health care workers report difficulties in navigating dementia care within the U.S. health care system. The report provides an in-depth look at the latest national and state-by-state statistics on Alzheimer's disease prevalence, mortality, caregiving, dementia care workforce and costs of care. The new report estimates that 6.9 million people age 65 and older in the U.S. are living with Alzheimer's dementia, with the cost of care for these individuals this year projected to reach $360 billion — a $15 billion increase from a year ago.

Key Points: 
  • This year's special report, Mapping a Better Future for Dementia Care Navigation, provides a comprehensive look into dementia care navigation by surveying dementia caregivers and health care workers on their experiences, challenges, awareness and perceptions of care navigation in dementia care.
  • Dementia care navigation provides clinical and nonclinical support to people living with dementia and their caregivers to overcome barriers that compromise care and health outcomes.
  • "Dementia care navigation programs have shown they can be a huge benefit to people living with dementia and their caregivers.
  • Get additional data and statistics from the report for Alzheimer's disease prevalence, mortality, cost of care, caregiving and dementia care workforce.

CHOP Researchers Find Branched Chain Amino Acid Supplementation May Aid in Concussion Recovery

Retrieved on: 
Tuesday, March 19, 2024
Online, Research, Mind, Stroke, Concussion, Assistant, CHOP, Critical Care Medicine (journal), Patient, DSM-IV codes, Journal, Anesthesiology, Leucine, Dana Foundation, Health, University, Doctor of Philosophy, MD, Human, Valine, Critical care, Adolescence, Isoleucine, Veteran, Clinical trial, BCAA, Pediatrics, Traumatic brain injury, National Institutes of Health, Hospital, Head injury, Randomized controlled trial, Safety, Ageing, HIT, Bangladesh Technical Education Board, Medicine, Children's Hospital of Philadelphia, MSCE, Dietary supplement

PHILADELPHIA, March 19, 2024 /PRNewswire/ -- In the first clinical trial of a targeted pharmacologic therapeutic for mild traumatic brain injury in pediatric patients, scientists from the Minds Matter Concussion Frontier Program at Children's Hospital of Philadelphia (CHOP) have found preliminary evidence that adolescents and young adults with concussion who take a specific formulation of branched chain amino acid (BCAA) supplements after injury experience faster symptom reduction and return to physical activity. The findings were published online by the Journal of Neurotrauma.

Key Points: 
  • The mainstay of treatment remains symptom management with temporary modification of cognitive and physical activity and over the counter medication.
  • Although active rehabilitation strategies have shown promise for improving recovery time, including aerobic, vestibular, and vision interventions, these can be time and labor intensive.
  • To date, no targeted pharmacologic intervention to improve clinical outcomes in concussion has been evaluated in humans.
  • However, prior to this study, no human studies involving adolescents and young adults have assessed the potential benefits of this formulation of BCAAs as a specific treatment to aid in concussion recovery.

OneSkin Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024

Retrieved on: 
Tuesday, March 19, 2024
SHIELD, Editorial, Culture, Organization, Antioxidant, FACE, EYE, Entrepreneurship, MIC, Journal of Cosmetic Dermatology, SAN, Journal, Research, AI, Hope, Doctor of Philosophy, Ageing, Human, Taco Bell, ITunes, Skin, Most, Fast, Nature Portfolio

SAN FRANCISCO, March 19, 2024 /PRNewswire-PRWeb/ -- OneSkin has been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2024.

Key Points: 
  • The best-in-class biotech skin health brand joins the ranks of Nvidia, YouTube, Taco Bell, and more
    SAN FRANCISCO, March 19, 2024 /PRNewswire-PRWeb/ -- OneSkin has been named to Fast Company's prestigious list of the World's Most Innovative Companies of 2024.
  • Alongside the World's 50 Most Innovative Companies, Fast Company recognizes 606 organizations across 58 sectors and regions.
  • ( Zonari, et al., Journal of Cosmetic Dermatology, 2024 )
    The World's Most Innovative Companies stands as Fast Company's hallmark franchise and one of its most anticipated editorial efforts of the year.
  • Fast Company's Most Innovative Companies package is available online , as well as in-app form via iTunes, and on newsstands beginning March 26.

Dow Jones and Columbia Journalism School Announce London Expansion of HBCU Media Collective

Retrieved on: 
Tuesday, March 19, 2024
Community, Inclusion, Sun, Dow Jones, Talksport, Partnership, Barron's, Virgin Radio, Howard University, SVP, Travel, Journal, The Sun, News, Columbia University, Editorial, Collective, Faculty, News Corp, Radio, Student, Morehouse College, HBCU, MarketWatch, Spelman College, Morgan State University, Times Radio, The Wall Street Journal, Florida A&M University, Journalism, The, Nursing

NEW YORK, March 19, 2024 /PRNewswire/ -- Dow Jones, a global provider of news and business information, and Columbia Journalism School today announced the expansion of the annual Historically Black Colleges and Universities (HBCU) Media Collective. Now in its second year, the HBCU Media Collective has added an international component to boost students' awareness of global opportunities while enhancing newsroom diversity and promoting financial literacy for participating students.

Key Points: 
  • NEW YORK, March 19, 2024 /PRNewswire/ -- Dow Jones, a global provider of news and business information, and Columbia Journalism School today announced the expansion of the annual Historically Black Colleges and Universities (HBCU) Media Collective.
  • "Our continued partnership with Dow Jones offers a dynamic, transformative opportunity to a second cohort of students," said Dr. Jelani Cobb, Dean of the Columbia Journalism School.
  • "The expansion of the HBCU Media Collective underscores the shared commitment we have with Columbia in developing bespoke learning opportunities to identify and mentor the next generation of aspiring journalists," said Brent Jones, SVP of Training, Culture & Community at Dow Jones.
  • The HBCU Media Collective is one of many opportunities Dow Jones offers to encourage careers in financial journalism and as part of its commitment to building an even stronger workplace culture.